What’s New @ FORCE
- FORCE Recommended Reads
- Update: PARP Inhibitor Research
- Brocade Study
- Personalizing Risk Assessment for BRCA1 and BRCA2 Mutation Carriers (Conference 2012 Recap)
- Genetic Testing in the Jewish Community—Are We Doing Enough? (Conference 2012 Recap)
- Breast Cancer Surveillance and Chemoprevention (Conference 2012 Recap)
- High-risk Breast Surveillance Resource Gaps
- Joining FORCEs Conference 2014
- Voices of FORCE and sidebar Conversations on the Impact of Hereditary Cancer in Our Lives
- Our New Collaboration with Basser Research Center
- Basser Research Projects
- What's New @ FORCE
Publication for High-risk Men
Thanks in part to a generous grant from Genomic Health, FORCE will develop an important communication for high-risk men: a brochure that will cover the cancer risks and standard-of-care recommendations for screening.
Electronic Newsletter Updates for Health Care Providers
In addition to our monthly national and regional update bulletins, we now provide a quarterly email bulletin for health care providers and researchers. This new communication features content that is tailored specifically for these health professionals to share articles about hereditary breast and ovarian cancer, research, advocacy initiatives, programs and resources. Visit our mailing list sign-up page if you would like to join our print or electronic mailing list.
Team FORCE Marine Corps Marathon Bibs Available
FORCE has been chosen as a charity partner of the 2013 Marine Corps Marathon, a 26.2-mile race through our nation’s capital, on October 27, 2013. Team FORCE members are guaranteed a spot in this sold-out race; if you’re a runner, help us raise funds to support FORCE’s lifesaving work for the HBOC community. A limited number of race bibs are available, so act fast! Contact Tina Krall at firstname.lastname@example.org for more information.
Disclaimer: Health links are made available for educational purposes only. This information should not be interpreted as medical advice. All health information should be discussed with your health care provider. Please read our full disclaimer for more information.
This site has been made possible by a generous grant from Morphotek.